I feel absolutely certain that you have stated things accurately. This is a situation where the technology is capable and the rapidity can help detect and identify Ebola so there can be better interdiction of its communication to others and effective precautions taken. I had been told years ago that the original tech did not work for viruses but what is exciting is that the Faro's expertise and the Company's development of the N-Assay obviously is a real "game changer" even as to viruses. This expands this technology's potential enormously. Since NanoLogix is a very small company without the kind of protected lab required to bring this to commercial levels it needs a partner that has the facilities and the financial clout to make it happen. I would hope the CDC gets on this immediately and assume the NanoLogix execs are in the process of contacting the right people.